Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.

Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Mar 2020
Historique:
pubmed: 8 2 2020
medline: 8 2 2020
entrez: 8 2 2020
Statut: ppublish

Résumé

The original version of this article unfortunately contained a mistake.

Identifiants

DOI: 10.1007/s00415-020-09715-5 PMID: 32030522 PMC: PMC7035215
pubmed: 32030522
doi: 10.1007/s00415-020-09715-5
pii: 10.1007/s00415-020-09715-5
pmc: PMC7035215
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

713-714

Commentaires et corrections

Type : ErratumFor

Auteurs

Alejandra González-Duarte (A)

Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Sección XVI, Tlalpan, CdMx, CP 01400, México City, Mexico. gonzalezduarte@aol.com.

John L Berk (JL)

Boston Medical Center, Boston, MA, USA.

Dianna Quan (D)

University of Colorado, Denver, CO, USA.

Michelle L Mauermann (ML)

Mayo Clinic, Rochester, MN, USA.

Hartmut H Schmidt (HH)

University of Münster, Münster, Germany.

Michael Polydefkis (M)

Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Márcia Waddington-Cruz (M)

Hospital Universitário Clementino Fraga Filho-UFRJ, Rio de Janeiro, Brazil.

Mitsuharu Ueda (M)

Kumamoto University Hospital, Kumamoto, Japan.

Isabel M Conceição (IM)

CHULN, Hospital de Santa Maria and Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.

Arnt V Kristen (AV)

University of Heidelberg, Heidelberg, Germany.

Teresa Coelho (T)

Hospital de Santo António, Centro Hospitalar Universitário Do Porto, Porto, Portugal.

Cécile A Cauquil (CA)

AP-HP Université Paris Saclay, CHU Bicêtre, Le Kremlin Bicêtre, France.

Céline Tard (C)

Université de Lille, Lille, France.

Madeline Merkel (M)

Alnylam Pharmaceuticals, Cambridge, MA, USA.

Emre Aldinc (E)

Alnylam Pharmaceuticals, Cambridge, MA, USA.

Jihong Chen (J)

Alnylam Pharmaceuticals, Cambridge, MA, USA.

Marianne T Sweetser (MT)

Alnylam Pharmaceuticals, Cambridge, MA, USA.

Jing Jing Wang (JJ)

Alnylam Pharmaceuticals, Cambridge, MA, USA.

David Adams (D)

AP-HP, Université Paris Saclay, CHU Bicêtre, Université Paris-Sud, INSERM 1195, Paris, France.

Classifications MeSH